Validation of a questionnaire to screen children for visual disorders
Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders
This study is testing a new questionnaire to help find out if children aged 3 to 12 have visual problems caused by brain issues, especially for French-speaking families.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 250 (estimated) |
| Ages | 3 Years and up |
| Sex | All |
| Sponsor | Université Catholique de Louvain Academic / other |
| Locations | 1 site (Louvain-la-Neuve) |
| Trial ID | NCT06997354 on ClinicalTrials.gov |
What this trial studies
This study aims to validate a questionnaire designed to screen children for cortical visual impairment (CVI), a condition where visual difficulties arise from brain damage rather than eye damage. The research focuses on children aged 3 to 12, particularly those whose parents are French speakers, to ensure accurate understanding of the questionnaire. By identifying children with CVI, the study seeks to improve diagnosis and care for this often-overlooked condition, which affects a significant percentage of young children. The study will involve both a clinical group of children showing signs of CVI and a control group without developmental issues.
Who should consider this trial
Good fit: Ideal candidates for this study are parents of children aged 3 to 12 who are French speakers and have concerns about their child's visual development.
Not a fit: Patients who do not have children within the specified age range or who do not speak French may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnosis and tailored interventions for children suffering from cortical visual impairment.
How similar studies have performed: While there is limited information on similar studies, the validation of screening tools for specific conditions like CVI is a recognized need, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parents of a child aged between 3 and 12 * Their mother tongue must be French, to ensure that they understand the questions asked in writing. Control group: \- Children of the parents surveyed who do not present any medical, school or family developmental particularities. Clinical group \- Children of the parents interviewed who present warning signs of CVI reported by a multidisciplinary team specialized in visual impairment. Exclusion Criteria: * no specific criteria (see inclusion criteria)
Where this trial is running
Louvain-la-Neuve
- 10 place cardinal Mercier — Louvain-la-Neuve, Belgium (Recruiting)
Study contacts
- Study coordinator: Anne Bragard, PhD
- Email: anne.bragard@uclouvain.be
- Phone: +3210474393
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.